Clinical Trial Update: A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating beta-hydroxybutyrate supplementation with radiotherapy followed by immunotherapy and CAPEOX neoadjuvant therapy in locally advanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• β-hydroxybutyrate (beta-hydroxybutyrate)

Snippet

Sponsor: Tao Zhang | Conditions: Rectal Cancer, Radiotherapy | Phase 2 | Status: RECRUITING